Trials / Conditions / MERS (Middle East Respiratory Syndrome)
MERS (Middle East Respiratory Syndrome)
5 registered clinical trials studyying MERS (Middle East Respiratory Syndrome).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS NCT04119440 | Universitätsklinikum Hamburg-Eppendorf | Phase 1 |
| Unknown | Study of Safety and Immunogenicity of BVRS-GamVac NCT04130594 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 1 / Phase 2 |
| Unknown | Study of Safety and Immunogenicity of BVRS-GamVac-Combi NCT04128059 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 1 / Phase 2 |
| Terminated | Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001) NCT03399578 | University of Oxford | Phase 1 |
| Completed | Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S NCT03615911 | Marylyn Addo | Phase 1 |